These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23442494)

  • 21. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term membranous glomerulonephritis as the presenting manifestation of systemic lupus erythematosus in a patient with human immunodeficiency virus infection.
    López-López L; González A; Vilá LM
    Lupus; 2012 Jul; 21(8):900-4. PubMed ID: 22249649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rifabutin as salvage therapy for cases of chronic multidrug-resistant pulmonary tuberculosis in Taiwan.
    Lee CN; Lin TP; Chang MF; Jimenez MV; Dolfi L; Olliaro P
    J Chemother; 1996 Apr; 8(2):137-43. PubMed ID: 8708745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis.
    Weiner M; Benator D; Peloquin CA; Burman W; Vernon A; Engle M; Khan A; Zhao Z;
    Clin Infect Dis; 2005 Nov; 41(9):1343-9. PubMed ID: 16206114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent antimycobacterial dosage correction.
    Slain D
    Clin Infect Dis; 2001 Jan; 32(2):321-2; author reply 323. PubMed ID: 11170930
    [No Abstract]   [Full Text] [Related]  

  • 27. Tolerability of twice-weekly rifabutin-isoniazid combinations versus daily isoniazid for latent tuberculosis in HIV-infected subjects: a pilot study.
    Matteelli A; Olliaro P; Signorini L; Cadeo G; Scalzini A; Bonazzi L; Caligaris S; Tomasoni L; Tebaldi A; Carosi G
    Int J Tuberc Lung Dis; 1999 Nov; 3(11):1043-6. PubMed ID: 10587327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urine trouble: genitourinary tuberculosis and subsequent DRESS syndrome.
    Czapka M; Shukla S; Slosar-Cheah M
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lopinavir pharmacokinetic profiles in HIV-infected patients during rifabutin-based anti-mycobacterial therapy.
    Matteelli A; Villani P; Carvalho AC; El-Hamad I; Cusato M; Apostoli A; Marcantoni C; Calabresi A; Dal Zoppo S; Bigoni S; Regazzi M
    J Antimicrob Chemother; 2012 Oct; 67(10):2470-3. PubMed ID: 22678727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [DRUG-INDUCED LUPUS CAUSED BY LONG TERM MINOCYCLINE TREATMENT FOR ACNE VULGARIS].
    Hanai S; Sato T; Takeda K; Nagatani K; Iwamoto M; Minota S
    Arerugi; 2015 Sep; 64(9):1269-73. PubMed ID: 26657914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rifabutin].
    Enferm Infecc Microbiol Clin; 1996 May; 14(5):329-30. PubMed ID: 8744377
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rifabutin-associated uveitis in a child.
    Olesen HH; Krag S
    Pediatr Infect Dis J; 2005 Nov; 24(11):1023-5. PubMed ID: 16282948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis.
    Burman W; Benator D; Vernon A; Khan A; Jones B; Silva C; Lahart C; Weis S; King B; Mangura B; Weiner M; El-Sadr W;
    Am J Respir Crit Care Med; 2006 Feb; 173(3):350-6. PubMed ID: 16109981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced lupus.
    Borchers AT; Keen CL; Gershwin ME
    Ann N Y Acad Sci; 2007 Jun; 1108():166-82. PubMed ID: 17893983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rifabutin-induced uveitis with inflammatory vitreous infiltrate.
    Khan MA; Singh J; Dhillon B
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():344-6. PubMed ID: 11026997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sweet syndrome associated with hydralazine-induced lupus erythematosus.
    Cartee TV; Chen SC
    Cutis; 2012 Mar; 89(3):121-4. PubMed ID: 22530328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of rifabutin, a rifamycin-group antibiotic, to patients with tuberculosis].
    Kekkaku; 2008 Oct; 83(10):679. PubMed ID: 19119512
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical experience with rifabutin in the treatment of mycobacterial infections.
    De Cian W; Sassella D; Wynne BA
    Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.